1. Home
  2. TRDA

TRDA

Entrada Therapeutics Inc.

Logo Entrada Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-18-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Founded: 2016 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 410.6M IPO Year: 2021
Target Price: $21.00 AVG Volume (30 days): 77.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.20 EPS Growth: N/A
52 Week Low/High: $10.62 - $18.44 Next Earning Date: 05-08-2024
Revenue: $129,013,000 Revenue Growth: N/A
Revenue Growth (this year): -38.82% Revenue Growth (next year): -50.66%

Share on Social Networks: